Objective: The INTERMED Self-Assessment questionnaire (IMSA) was developed as an alternative to the observer-rated INTERMED (IM) to assess biopsychosocial complexity and health care needs. We studied feasibility, reliability, and validity of the IMSA within a large and heterogeneous international sample of adult hospital inpatients and outpatients as well as its predictive value for health care use (HCU) and quality of life (QoL). Methods: A total of 850 participants aged 17 to 90 years from five countries completed the IMSA and were evaluated with the IM. The following measurement properties were determined: feasibility by percentages of missing values; reliability by Cronbach α; interrater agreement by intraclass correlation coefficients; convergent validity of IMSA scores with mental health (Short Form 36 emotional well-being subscale and Hospital Anxiety and Depression Scale), medical health (Cumulative Illness Rating Scale) and QoL (Euroqol-5D) by Spearman rank correlations; and predictive validity of IMSA scores with HCU and QoL by (generalized) linear mixed models. Results: Feasibility, face validity, and reliability (Cronbach α = 0.80) were satisfactory. Intraclass correlation coefficient between IMSA and IM total scores was .78 (95% CI = .75-.81). Correlations of the IMSAwith the Short Form 36, Hospital Anxiety and Depression Scale, Cumulative Illness Rating Scale, and Euroqol-5D (convergent validity) were −.65, .15, .28, and −.59, respectively. The IMSA significantly predicted QoL and also HCU (emergency department visits, hospitalization, outpatient visits, and diagnostic examinations) after 3-and 6-month follow-up. Results were comparable between hospital sites, inpatients and outpatients, as well as age groups. Conclusions: The IMSA is a generic and time-efficient method to assess biopsychosocial complexity and to provide guidance for multidisciplinary care trajectories in adult patients, with good reliability and validity across different cultures.
INTRODUCTION D
iseases emerge in the context of complex interactions between biological, psychological, and social factors resulting in very specific, individual patterns of need and complexity. High biopsychosocial complexity is associated with negative health outcomes such as multimorbidity (1) , longer disease duration (2) , reduced clinical improvement (3) , and increased risk of mortality (4) . In addition, biopsychosocial complexity relates to lower quality of life (QoL, (5) ) and increased use of health care resources such as doctor or hospital visits (6-9), higher admission rates (6, 8, 10) , and longer hospital stays (1) . The impact of biopsychosocial complexity on health outcomes and care use underlines the importance of taking into account biopsychosocial complexity at an early stage so that care can be tailored adequately.
With this objective, the INTERMED (IM) method has been developed as a semistructured interview to identify a patient's degree of complexity and care needs from a biological, psychological, social, and health care-related perspective (11, 12) , on the basis of the temporal perspective of past, present, and future. The name IM was assigned to this instrument by its developers, as a reference to INTERplay and INTEgration of MEDicine. The IM has been proven to be valid and reliable (11, 12) and its use facilitates and improves (early integrated) care (2, (11) (12) (13) (14) (15) (16) (17) (18) (19) , with a positive effect on medical and psychiatric outcomes (2, 11, 12, 15) .
Despite its added value, the IM has not been widely implemented in clinical practice. Reasons for this are that the IM interview requires training, which is difficult to provide given the turnover of personnel. Moreover, assessment with the IM is relatively time-consuming, especially in the light of increasing efficiency demands on the health care system.
To overcome the practical drawbacks of implementing the IM, a self-administered version was developed: the IM self-assessment questionnaire (IMSA). Because the IMSA is completed by the patient, its use does not require training and is not time-consuming for health professionals. A previous similar adaptation of the IM for elderly populations (IM-E) into a self-assessment version (i.e., the IM-E-SA) has already been demonstrated to have good psychometric properties (20) . The differences between the IMSA and the IM-E-SA are that the IM-E-SA has no questions related to occupational activities and has an extra item on whether patients live by the day and do not think about possible changes (in prognosis) in the future.
In the current study, we aimed to investigate the measurement properties of the IMSA. For this purpose, we aimed to compare the IMSA with the IM and to assess whether patients judged the IMSA to be appropriate and comprehensive. Moreover, we aimed to assess convergent validity by relating the biopsychosocial characteristics of the IMSA to related concepts that were similar (i.e., relating biological complexity to the number of illnesses present, general severity of medical problems and QoL; psychological complexity to current emotional well-being and symptoms of depression and anxiety). In addition to the measurement properties of the IMSA, we studied its predictive validity; whether biopsychosocial complexity predicted lower QoL and increased health care use (HCU) at 3-and 6-month follow-up. This was to provide a clear indication of the burden and medical consumption that arises from biopsychosocial complexity in the short and longer term. We also examined whether the measurement properties and predictive value of the IMSA were similar between various patient groups and thus whether the IMSA can be considered as a generic tool. Inpatients and outpatients of different ages and departments were recruited from hospitals in Germany, France, Italy, The Netherlands, and Switzerland, which permitted the study of generalizability. We hypothesized moderate to substantial concordance between the IMSA and IM, because the instruments assess biopsychosocial complexity from an individual's versus a professional's perspective. We also hypothesized that statistically higher IMSA total scores would be found in patients with more diseases. Furthermore, we expected moderate to strong correlations of the IMSA biological domain with severity of medical problems and of the IMSA psychological domain with mental health. Moreover, we assumed moderate to high negative correlations of IMSA scores with QoL because these are opposing constructs (21) . Finally, we hypothesized that biopsychosocial complexity relates to increased HCU and QoL over time.
METHODS

Participants
Participants (n = 850) of the IM self-assessment (IMSA) study, an international multisite longitudinal cohort study, were recruited from hospitals in the following sites: Freiburg, Germany (n = 86 oncology inpatients of the University Medical Center [UMC]); Nantes, France (n = 111 endocrinology inpatients, with diagnoses of diabetes mellitus and/or obesity); Modena, Italy (n = 96 liver outpatients); Amsterdam, The Netherlands (n = 129 rehabilitation and cardiology outpatients of the Academic Medical Center Amsterdam, and n = 160 medical psychiatric unit, internal medicine, gastroenterology and nephrology inpatients of the VU Medical Center); Sion, Switzerland (n = 175 inpatients); and Lausanne, Switzerland (n = 93 rheumatology inpatients). Data were collected between May 2011 and June 2014, for roughly 6 months each site, with precise collection periods slightly different per site. The study protocol was approved by ethical review boards of all participating centers and participants signed informed consent at baseline. Patients who were too ill to participate (n = 130), refused (n = 444), had language difficulties (n = 32), were mentally confused (n = 27), released from hospital early (n = 507) or died (n = 5) were excluded from the study. A total of 50.3% of the excluded patients were female.
Measurements
Baseline
The baseline assessment consisted of a face-to-face interview (comprising the IM, Cumulative Illness Rating Scale [CIRS] and sociodemographic data) by a trained doctor, nurse, or intern, as well as written questionnaires (IMSA, Hospital Anxiety and Depression Scale [HADS], Short Form [SF] 36 and EuroQol-5D [EQ-5D]), all conducted in the national language. Participants were asked to complete all written questionnaires in-person before the interview; inpatients completed the questionnaires at the hospital and outpatients at the hospital in a (private) waiting room or at home.
The IM, by means of a semistructured interview, assesses health care needs in the following four domains: biological, psychological, social, and health care (11, 12) . Each domain is covered by five questions in the context of time (history, current state, and prognosis). In total, the instrument consists of 20 four-point rating scale items (range, 0-3; higher scores indicating higher levels of complexity), which are summed to a total complexity score (range, 0-60). More detailed substantive information is available elsewhere (11) .
The IM self-assessment (IMSA) is a modified version of the IM, completed by the patient. It contains the same domains and contexts of time as the IM, except for the items on historical biological chronicity (item number 1), current diagnostic/therapeutic challenge (item number 4), as well as work and leisure activities (item number 9), which were changed from one item into two to foster clarity. For the total score, scores of these three items are recoded back to one pooled score (see appendix, Supplemental Digital Content 1, http://links.lww.com/PSYMED/A357). Because of language difficulties or severe illness, some participants could not fill in the IMSA by themselves. For these patients, the IMSA was completed by or with the help of a family member or health care professional. The IMSA is available in different languages via www.intermedconsortium.com.
Face validity of the IMSA according to participants was assessed by additional questions, that is, "Do you think that these questions were appropriate to ask?" (yes/no) and "Did we miss issues pertinent to your care?" (yes [please specify]/no).
The CIRS is a clinician-rated review of medical problems of 14 organ systems, based on a 0 to 4 rating of severity, yielding a cumulative score of 0 to 56 (22) . The internal consistency (α = .73) of the CIRS is acceptable (23).
The Hospital Anxiety and Depression Scale (HADS, (24) ) is a selfreport screening scale consisting of seven anxiety and seven depression items (a total of 14 questions) covering last week. It is scored on a fourpoint Likert scale (0-3), with an overall score ranging from 0 to 21 for both (anxiety and depression) scales and from 0 to 42 in total. Higher scores indicate more symptoms. Both the anxiety and the depression scale show good to acceptable (α = .80 and .76, respectively) internal consistency (25) .
The Short Form (SF) 36 is a self-assessment health questionnaire, based on the World Health Organization definition of health (26) . We used the emotional well-being subscale, averaging items 24, 25, 26, 28, and 30, with item scores ranging from 0 to 100 and a score of 100, indicating the highest rating of good health (27) . This subscale has excellent (α = .95) internal consistency (28) .
The EuroQol-5D (EQ-5D) measures health-related QoL and consists of the following five domains: mobility, self-care, pain, usual activities, and psychological status (29) . Answer categories comprise no/some/severe problems, and afterward, the health state of an individual was calculated with a scoring algorithm (30, 31) . The scores on the EQ-5D can vary 96 (11) Switzerland (Lausanne) 94 (11) Switzerland (Sion) 175 (21) France (Nantes) 111 ( between −0.59 (worst health) and 1.00 (perfect health). The internal consistency (α = .74) of the EQ-5D is acceptable (32) . We used both the Short Form 36 (SF-36) and the EQ-5D because this was performed in a similar study on the measurement properties of the IM for elderly populations (the IM-E-SA, (20) ). Sociodemographic data collected included age, sex, and years of education.
Follow-Up After 3 and 6 Months
Three and six months after baseline, participants returned a postal questionnaire consisting of the SF-36, the EQ-5D, and HCU. HCU included the self-reported number of visits to an emergency department (ED), days of hospital admissions, outpatient contacts with medical specialists, and diagnostic tests (such as x-ray, blood test, or ultrasound) for the past 3 months. This method to assess HCU has been used in previous research (19) . Participants who were included in the follow-up were biopsychosocially less complex (mean IMSA total score, 16.3 versus 18.6, p < .001), older (mean age, 54.3 versus 48.8, p < .001), and had better emotional well-being (SF-36 score, 65.0 versus 58.5, p < .001) than those who did not, but they did not differ regarding sex, years of education, depressive or anxiety symptoms (HADS), number of diseases (CIRS), or QoL (EQ-5D).
Statistical Analyses
Baseline missing values on the IM, IMSA, SF-36 emotional well-being subscale, and HADS were mean imputed on case level when more than 25% of the items were missing. Expectation maximization (EM) was used to impute the remaining 2.8% missing data. EM is a method to impute missing data, in which other variables are used to estimate the most likely value of missing data (expectation), and then, it is checked whether that really is the most likely value (maximization). If not, a more likely value is reimputed and checked until the most likely value is reached. EM imputations are more reliable than mean imputations because they take into account the relationship with other variables. Baseline and follow-up sample characteristics were described using medians and interquartile as well as total ranges for the nonnormally distributed quantitative variables and percentages for categorical variables.
Feasibility of the IMSAwas assessed by percentage of participants with a maximum of 15% missing values (i.e., 3 of all 20 items) within the IMSA, as has been done previously (20) . Moreover, face validity according to participants was calculated as the percentage of participants who found the questions of the IMSA appropriate to ask and the percentage of participants who thought that the IMSA did not miss issues pertinent to their care.
Reliability of the IMSA was studied in terms of internal consistency of the IMSA and of concordance between the IMSA and IM.
Internal consistency of the IMSA was calculated by Cronbach α; an α value greater than .70 indicates satisfactory internal consistency of a scale (33) .
Interrater agreement of IMSA with IM total and domain scores was calculated with intraclass correlation coefficients (ICCs) using two-way mixed models for absolute agreement. ICCs can be interpreted as almost perfect (.81-1.00), substantial (.61-.80), moderate (.41-.60), fair (.21-.40), slight (.00-.20), and poor (<.0) agreement (34) .
Construct validity of the IMSA was assessed in terms of known-group validity and convergent validity.
Known-group validity was defined as whether patients with more diseases (i.e., ≤1, 2, or ≥3 according to the CIRS) had higher IMSA scores. The statistical differences between subgroups were assessed with MannWhitney U test for nonnormally distributed data.
Convergent validity of the IMSA with the IM, medical health (CIRS), mental health (SF-36 emotional well-being subscale and HADS), and QoL (higher scores on the IMSA were hypothesized to be correlated with lower QoL and thus with lower EQ-5D scores) were calculated by Spearman rank correlations. Standard interpretations of the correlation coefficients were applied; .00 to .29 was considered weak, .30 to .69 was considered moderate, and .70 to 1.00 was considered strong (33) .
Predictive validity of the IMSA for QoL and HCU was calculated by (generalized) linear mixed models, regressing the outcome variables EQ-5D and HCU on IMSA score. Two time variables (i.e., 3-and 6-month follow-up) and two IMSA score by time variable interaction terms (i.e., IMSA score Â 3-month follow-up and IMSA score Â 6-month follow-up) were taken into account. For the predictive analyses on EQ-5D, a linear model was used to control for baseline EQ-5D score. For predictive analyses on HCU, Poisson models were used, controlling for being an inpatient at baseline. We expected that higher complexity according to the IMSA would be related to a further reduction in QoL and to increased HCU.
The optimal cutoff point for the IMSA (i.e., test variable) fitting the IM cutoff point of 21 (i.e., the dichotomous state variable) for general complexity was calculated by receiver operating characteristic curve analysis determining optimal sensitivity and specificity (35) .
We repeated all analyses to evaluate the feasibility, reliability, construct validity, and predictive validity among all seven hospital sites (see appendix, Supplemental Digital Content 2, http://links.lww.com/ PSYMED/A358), among inpatients and outpatients and among Mental health (SF-36) −.65
Mental health (HADS) .15
QoL (EQ-5D) −.59 IMSA = INTERMED Self-Assessment; IM, INTERMED; CIRS = Cumulative Illness Rating Scale; SF-36 = Short Form 36; HADS = Hospital Anxiety and Depression Scale; QoL = quality of life; EQ-5D = EuroQol-5D. a Convergent validity in n = 850 of the IMSA total and domain scores with IM total and domain scores, severity of medical problems (CIRS total score), mental health (SF-36 and HADS), and QoL (EQ-5D). Calculated with Spearman rank correlations. All p < .001 were also significant after Bonferroni correction (at the Bonferronicorrected threshold α .006). Predictive validity of the IMSA total scores with HCU and QoL after 3-(n = 569) and 6-month (n = 512) follow-up. Regression parameters estimated from (generalized) linear mixed models, regressing the outcome variable on IMSA score. Two time variables (i.e., 3-and 6-mo follow-up) and two IMSA score by time variable interaction terms (i.e., IMSA score Â 3-month follow-up and IMSA score Â 6-month follow-up) were taken into account. For the predictive analyses on EQ-5D, a linear model was used controlling for baseline EQ-5D score. For predictive analyses on HCU, Poisson models were used, controlling for being an inpatient at baseline. We expected that higher complexity according to the IMSA would be related to a further reduction in QoL and to increased HCU. participants aged younger and older than the group median of 53 years, to study international generalizability and generalizability among inpatients and outpatients as well as across ages. Statistical significance was inferred at a p value of less than .05. All statistical analyses were performed using SPSS 22.0 (IBM Company, Chicago, Ill).
RESULTS
Sample characteristics are shown in Table 1 . Almost three quarter of our sample consisted inpatients, 39.1% of the participants were female, and the median age was 54 years (interquartile range, 43-64), with a range of 17 to 90 years. The majority was multimorbid, and 36.7% were complex according to the original IM cutoff of 21 for general complexity. Of the original sample (n = 850), 569 participants (66.9%) were available for 3-month follow-up and 512 participants (60.2%) for 6-month follow-up.
Feasibility
None of the participants reached the threshold for feasibility of 15% missing values on items of the IMSA; only 1.5% showed one missing item and the rest had no missing items on the IMSA.
Face Validity According to Participants
Ninety-seven percent of the participants found the questions of the IMSA appropriate to ask and 96% considered that the IMSA did not miss issues pertinent to their care.
Reliability
Cronbach α value of the IMSA was 0.80, which is considered as a satisfactory internal consistency.
Interrater Agreement
Interrater agreement between the IMSA and IM total scores as assessed by the ICC was .78 (95% confidence interval [CI] = .75-.81). ICCs for the IMSA domains were as follows: biological, .66 (95% CI = .61-.70); psychological, .73 (95% CI = .69-.77); social, .71 (95% CI = .66-.74); and health care .49 (95% CI = .42-.55). These values indicate moderate to substantial concordance between the IMSA and IM.
Construct Validity
Known-Group Validity
Participants with more diseases/disorders showed statistically significantly higher IMSA scores (p < .001).
Convergent Validity
The correlations between the IMSA scores and comparable constructs ranged from .15 to −.65 (Table 2) .
Predictive Validity
The IMSA significantly predicted HCU (i.e., number of ED visits, hospital admissions, outpatient visits, and diagnostic examinations) and QoL after 3-and 6-month follow-up (Table 3) . Although QoL increased more over time among complex patients than among noncomplex patients, QoL remained lower in complex patients.
According to the IM, the optimal cutoff point of the IMSA for detecting complex patients was 19.
Results on imputed data were comparable with results on original data. Repeated main analyses among hospital sites, among inpatients and outpatients, and among participants younger and older than the group median of 53 years, with the purpose of studying international generalizability and generalizability among inpatients and outpatients and across ages yielded largely similar results. Analyses on data from Freiburg and Sion showed more than 10% lower ICC and convergent validity values, but post hoc analyses excluding these data did not significantly affect pooled results.
DISCUSSION
With this large international sample of hospital inpatients and outpatients of different ages and with various diseases, we aimed to assess the feasibility, reliability, and validity of the IMSA, as well as its predictive value for HCU and QoL. The IMSA seems to be a feasible, reliable, and valid alternative to the clinicianadministered IM. The results apply to inpatient and outpatient settings across all five European countries and all adult ages. Biopsychosocial complexity predicted increased HCU and lower QoL upon 3-and 6-month follow-up.
The feasibility of the IMSA was good because only a very small percentage (i.e., 1.5%) of the participants did not entirely complete the IMSA; the fact that most patients considered the questions of the IMSA appropriate to ask might be responsible for this result. These findings encourage implementation of the IMSA in clinical practice.
Reliability of the IMSAwas demonstrated by both a good internal consistency of items and adequate interrater agreement. The satisfactory internal consistency of the IMSA is similar to the good internal consistency of the original IM (6, 11) . The interrater agreement between the IMSA and IM was moderate to substantial, which indicates that professionals and patients judge their complexity rather similarly, supporting the usefulness of the IMSA as an alternative to the IM. The lower cutoff point (19) for general biopsychosocial complexity of the IMSA (cutoff point of 21 for the IM) is in line with the validation study of the IM-E-SA; elderly patients also rated their biopsychosocial complexity lower than clinicians did (20) . Patients may rate their situation as less complex than observing professionals because they have different perspectives on reality, also known as the emic and etic view (36) . Although professionals focus on delivering appropriate care, patients have other priorities. A tendency among patients to trivialize problems might also emerge in a process of resilience, helpful to maintain or regain mental health during physical illness (37) . Resilient adaptation may also explain the finding that more complex patients had a higher increase in QoL over time than noncomplex patients. Although a cutoff point exists for the total score of both the IM and the IMSA as an indicator of general complexity, a cutoff is arbitrary. The scores on the subscales, rather than the total scores, are more informative to regulate clinical management and remain most useful to regulate treatment; high scores on single subscales indicate that an individual patient might have specific care needs in that area and these should be the focus of conversations with the patient and of care plans that add value to the patients and their QoL.
With regard to construct validity, as expected, high complex patients had more diseases and a lower QoL. The IMSA related to the IM and to lower QoL. Biological complexity related to general severity of medical conditions. Psychological complexity related to generally experienced emotional well-being (SF-36) but unexpectedly only weakly to current symptoms of depression and anxiety (HADS). This may be explained by the fact that the IMSA and the SF-36 focus on mental health in general (including coping and compliance), whereas the HADS focuses on anxiety and depression symptoms specifically. Furthermore, the HADS only covers the previous week and is therefore only a "snapshot," whereas the psychological domains of the IMSA and the SF-36 are both conceptually as well as temporally broader. Future research should clarify this finding.
Biopsychosocial complexity predicted HCU and lower QoL in the short and longer term (i.e., after 3 and 6 months). The finding that complexity predicted HCU is in line with earlier findings that biopsychosocial complexity increases number of outpatient (6, 9) and ED visits (6, 8) , as well as hospital admissions (6, 8, 9) . The relationship of biological (38, 39) , psychological (40, 41) , and social complexity (42) with lower QoL has also been established in previous research. Consequently, the unfavorable association of biopsychosocial complexity with future HCU and QoL stresses the importance of developing targeted clinical interventions to improve biopsychosocial functioning at an early stage of care and to improve QoL and medical outcomes to reduce HCU in the longer run.
Despite the encouraging results with regard to reliability and validity of the IMSA, the present study has limitations. First, we did not include discriminatory concepts, and extensive analysis of discriminant validity was therefore not possible. A second limitation is that although the participation rate was approximately 43%, some patients were excluded for reasons of vulnerability (10% were either too ill to participate, mentally confused, died, or had language problems), resilience (25% early dismissed), or other reasons (22% refused). In addition, we did not have sufficient information to be able to extensively compare excluded patients with participants. Although loss of participants in inevitable, this made it impossible to extensively assess selection bias and thus makes it uncertain whether the patient populations that were studied are truly representative. A third limitation is that QoL, depression, and anxiety were assessed with self-assessment questionnaires only, whereas assessment of these concepts with an interview might have provided additional information. HCU was assessed by self-report as well, whereas chart review might have been more reliable. A final limitation is that those administering the IM were not formally blinded for the self-administered questionnaires. Although in practice, self-administered questionnaires were generally not previewed by the administers, in cases of preview, this may have affected the scoring of the IM. Despite these limitation, the major strengths of the study are the extensive and longitudinal psychometric evaluation of the IMSA in a clinically heterogeneous international population, thus supporting the generalizability of results.
The IMSA seems to have good measurement properties and is therefore a promising alternative to the IM for a variety of patient populations and health care settings. The IMSA could therefore be used as a generic, cross-culture, and time-efficient method for professionals to assess biopsychosocial complexity of patients and to provide guidance for multidisciplinary care trajectories and interdisciplinary communication (15) (16) (17) . If desired, the IMSA can be assessed orally as an interview (as an alternative to the IM) or additional questions can be asked in dialogue with the patient to clarify care needs. This would support shared decision making as a basis of treatment plans, resulting in improved QoL of the individual patient and prevention of inadequate HCU in the future. Future research should focus on the benefits of implementing the IMSA in clinical settings, to initiate early interventions tailored to the patient's needs and to evaluate subsequent outcomes of the complex medically ill.
